glp-1 cardiovascular outcomes 2025 news GLP-1s Could Improve Heart Health - PAD Treatment Centers What Ozempic and other GLP-1

An additional 4mg yielded only 1.4 percentage points of additional weight loss, while side effects increased notably

Psychopharmacology 236 , 603611 (2019)

True Value Score: A Pricing Medication Costs Insurance Cancellations, Refunds, and Commitment Terms Shed requires a minimum two-month commitment, and cancellations must be made at least 72 hours before the next billing cycle to avoid charges

Moreover, existing data indicate that single-target GLP-1RAs such as SEMA and liraglutide show promising capabilities for fibrosis improvement, and the initial success of the dual agonist tirzepatide suggests potential benefits of dose titration therapy in the monotherapy management of MASLD

Semaglutide is the established gold standard with FDA approval, proven cardiovascular benefit, extensive clinical data, and multiple formulation options

Scientific Reference 2: Wilding et al., New England Journal of Medicine (2021) 2